Arkolith/Insider Trading/VERA/Form 4

Young Joseph R

SVP, FINANCE, CHIEF ACCT OFFCRVera Therapeutics, Inc. (VERA) · full profile →Form 4 · filed Nov 13, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$436K
Net Open-Market Flow
-$436K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 13, 2025Option exercise(M)10K$3.94$39K58K
Nov 11, 2025Sell(S)15K$29.06$436K48K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 13, 2025Option exercise(M)10K—$049K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-280792) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML